| Patents for C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms (11,132) |
|---|
| 02/09/2006 | CA2571786A1 Prostaglandin analogs |
| 02/08/2006 | CN1730476A Aromatic amine ketone compounds, its synthesis method, pharmaceutical composition containing same and uses |
| 02/07/2006 | US6995224 Isoprene-styrene copolymer, butadiene-styrene copolymer or butadiene-isoprene-styrene terpolymer randomly modified from 1-5%, e.g., of an p-(2-pyrrolidinoisopropyl-)styrene; tire tread; filler receptivity; low hysterises; rolling resistance; |
| 02/07/2006 | CA2360308C Glucocorticoid receptor modulators |
| 02/02/2006 | WO2006011466A1 5-substituted-2-phenylamino-benzamide as mek inhibitor |
| 02/02/2006 | WO2005047245A3 Fluorescence assays with improved blocking groups |
| 02/02/2006 | US20060025416 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| 02/02/2006 | US20060025404 Such as 1-(4-{[1-(1-methylethyl)-4-piperidinyl]oxy}phenyl)-4-{[4-(methylsulfonyl)phenyl]carbonyl}piperazine; neurodegenerative disorders including Alzheimer's disease; allergic rhinitis |
| 02/02/2006 | DE102004033021A1 Liquid pressure transmitting medium, useful in hydraulic component or machines, comprises ionic liquid as pressure transmitting medium |
| 02/01/2006 | EP1621566A1 Fluxing no-flow underfill composition containing benzoxazines |
| 02/01/2006 | EP1620445A2 Method and compositions for identifying anti-hiv therapeutic compounds |
| 02/01/2006 | EP1500654B1 Benzoxazinone derivatives, the preparation and use thereof as medicaments |
| 02/01/2006 | CN1727339A Tricyclic compounds, their production and use |
| 02/01/2006 | CN1239509C Flame-proofing agents |
| 02/01/2006 | CN1239497C Intermediate product for preparing aralkyl and aryl alkylene heterocyclic lactam and imide |
| 01/31/2006 | US6992083 Benzoxazol derivatives |
| 01/31/2006 | US6991914 Hydrolysis of 3,7-dialkanoyloxyphenoxazine derivative; measuring fluorescence |
| 01/26/2006 | WO2006010142A2 Mineralocorticoid receptor modulator compounds, processes for their preparation, and their use |
| 01/26/2006 | WO2005077463A3 Ligand for a monoamine receptor or transporter for treating addiction or dependence |
| 01/26/2006 | US20060020131 Aryl amide, -sulfonamide, or -urea derivatives; antiproliferative, antitumor, anticarcinogenic, and/or antimetastasis agents |
| 01/26/2006 | DE102004032421A1 Phenylsubstituierte [1.2]-Oxazin-3,5-dion-und Dihydropyron-Derivate Phenyl-substituted [1.2] oxazine-3,5-dione derivatives and dihydropyrone |
| 01/25/2006 | EP1619230A1 Red light emitting compounds for organic electroluminescent devices and organic electroluminescent devices using them |
| 01/25/2006 | EP1617856A2 Somatostatin-dopamine chimeric analogs |
| 01/25/2006 | EP1506179B1 Benzoxazine derivatives as 5-ht6 modulators and uses thereof |
| 01/25/2006 | CN1726201A Substituted piperazines,(1,4) diaszepines, and 2,5-diazabicyclo (2.2.1)iieptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists |
| 01/25/2006 | CN1724537A Method of synthesizing methanesulfonic acid parzhushaxing intermedinte |
| 01/25/2006 | CN1238348C Oxazin(thio)one compounds used as fungicides |
| 01/24/2006 | US6989402 Thyroid receptor ligands and method II |
| 01/19/2006 | US20060014947 Levofloxicin prepared by reduction of an entantiomorph of 2,3,4 trihalo,N-(1-alkoxycarbonylethyl-)aniline by a metal borohydride in an aprotic solvent and alcohol; reacting the product with a 2,2-dialkoxycarbonyl-ethyl halide; cyclization using a base and phase transfer agents; optical purity;efficiency |
| 01/19/2006 | US20060014946 Method for making acylamides by synthesizing and acylating benzoxazines |
| 01/19/2006 | US20060014739 Androgen receptor modulators and method of treating disease using the same |
| 01/19/2006 | CA2573611A1 Agent for promoting the recovery from dysfunction after the onset of central neurological disease |
| 01/19/2006 | CA2571178A1 2-substituted heteroaryl compounds |
| 01/18/2006 | EP1615699A2 Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors |
| 01/18/2006 | CN1723207A Inhibitors of histone deacetylase |
| 01/18/2006 | CN1723205A Substituted benzoxazinones and uses thereof |
| 01/18/2006 | CN1723023A morpholine derivatives for use as dopamine agonists in the treatment of I.A. sexual dysfunction |
| 01/17/2006 | US6987084 Photo-labile pro-fragrance conjugates |
| 01/12/2006 | WO2006002810A1 Phenyl substituted [1.2]-oxazine-3,5-dione and dihydropyrone derivatives |
| 01/12/2006 | US20060009641 Crystal forms of (-)-6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxazin-2-one |
| 01/12/2006 | CA2576208A1 Phenyl substituted [1.2]-oxazine-3,5-dione and dihydropyrone derivatives |
| 01/11/2006 | EP1614678A2 Sulfur substituted sulfonylaminocarboxylic acid N-heteroarylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 01/11/2006 | EP1613762A2 Process for producing enantiopure beta-amino acid derivatives, and enantiopure beta-amino acid derivatives |
| 01/11/2006 | EP1613621A1 Prostaglandin analogs as ep4 receptor agonists |
| 01/11/2006 | CN1718579A Asparagic acid levo oxyfluorsaxin and its preparation method |
| 01/05/2006 | WO2006000401A1 Substituted oxazines as glucocorticoid receptor modulators |
| 01/05/2006 | WO2004092167A8 Beta-carbolines useful for treating inflammatory disease |
| 01/05/2006 | WO2004091504A3 Substituted quinobenzoxazine analogs |
| 01/05/2006 | US20060003998 2-(2-Methoxy-phenyl)-1-morpholin-2-yl-1-phenyl-ethanol hydrochloride; selective inhibitors of the reuptake of norepinephrine; in membrane cells of central nervous system; anxiolitic agent, cognition activator, psycological disorder |
| 01/05/2006 | DE102004024453A1 Neue langwirksame Bronchodilatoren zur Behandlung von Atemwegserkrankungen New long-acting bronchodilators for the treatment of respiratory disorders |
| 01/05/2006 | CA2572135A1 Sulfonamide compound |
| 01/04/2006 | EP1611134A1 Beta-carbolines useful for treating inflammatory disease |
| 01/04/2006 | EP1611114A2 Amine-substituted diphenyldiphosphines |
| 01/04/2006 | EP1610759A2 Substituted quinobenzoxazine analogs |
| 01/04/2006 | EP1610753A2 Phenylenediamine urotensin-ii receptor antagonists and ccr-9 antagonists |
| 01/04/2006 | EP1363873A4 Peptide deformylase inhibitors |
| 01/04/2006 | CN1717395A Reactive materials for limited play optical devices and methods of making same |
| 01/04/2006 | CN1234697C Method of producing N-substituted 2, 6-dialdyl morpholines |
| 01/03/2006 | CA2359476C Hypolipidemic and antioxidant morpholine derivatives |
| 01/03/2006 | CA2156289C Drug composition containing nucleic acid copolymer |
| 12/29/2005 | US20050288350 Useful in female hormone replacement therapy and as modulators of fertility; therapy of dysfunctional uterine bleeding, dysmenorrhea, endometriosis, leiomyomas (uterine fibroids), hot flashes, mood disorders, meningiomas, cancer; 6-(bis-2,2,2-Trifluoroethyl)amino-4-trifluoromethylcoumarin |
| 12/29/2005 | US20050288282 Anticancer agents; antiproliferative agents |
| 12/29/2005 | US20050288262 such as 3,10-Dibenzyloxyminocycline, used to treat bacterial infections and neoplasms, as well as blocking tetracycline efflux and modulation of gene expression |
| 12/28/2005 | EP1608619A1 Muscarinic agonists |
| 12/28/2005 | CN1714079A Mandelic acid derivatives |
| 12/28/2005 | CN1713914A Novel medicaments for the treatment of chronic obstructive pulmonary diseases |
| 12/22/2005 | WO2005060663A3 Derivatives of gambogic acid and analogs as activators of caspases and inducers of apoptosis |
| 12/22/2005 | US20050282905 Hydroxamic acid derivative and mmp inhibitor containing the same as active ingredient |
| 12/21/2005 | EP1607393A1 Compositions comprising hydroalkylated direct dyestuffs, process for implementing and use |
| 12/21/2005 | EP1363897B1 Antagonists of mcp-1 function and methods of use thereof |
| 12/21/2005 | CN1709878A 2H-3,1-benzo oxole heterocyclic compound hynthesizing method |
| 12/20/2005 | US6977299 Method for making acylamides by synthesizing and acylating benzoxazines |
| 12/15/2005 | WO2005118562A1 New isobenzoxazinones and their use as ultraviolet light absorbers |
| 12/15/2005 | US20050277646 N-[4-({5-(4-fluorophenyl)-4-[4-(trifluoromethyl)phenyl]pyridin-2-yl}oxy)-1,3-benzothiazol-2-yl]acetamide; vanilloid (capsaicin) receptor antagonist/agonist; antiinflammatory, analgesic, antiarthritis, antirheumatic; diseases involving sensory nerve function |
| 12/15/2005 | US20050277632 2-Hydroxyethylamines 2-substituted by a hydroxy-N-heterocycle and N-substituted by an omega-phenyl-1,1-dimethylalkyl group: 6-hydroxy-8-{1-hydroxy-2-[2-(4-methoxy-phenyl)-1,1-dimethyl-ethylamino]-ethyl}-2,2-dimethyl-4H-benzo[1,4]oxazin-3-one; betamimetics |
| 12/15/2005 | US20050277631 Vanilloid receptor ligands and their use in treatments |
| 12/15/2005 | US20050276754 Bridged aromatic substituted amine ligands with donor atoms |
| 12/14/2005 | EP1603880A1 Quinolinone/benzoxazinone derivatives and uses thereof |
| 12/14/2005 | EP1603562A2 Sulfonyl-amidino containing and tetrahydropyrimidino containing compounds as factor xa inhibitors |
| 12/14/2005 | EP1224165B1 Novel compounds |
| 12/14/2005 | CN1708480A Carotenoid analogs for the inhibition and amelioration of disease |
| 12/14/2005 | CN1231531C UV absorbent composition for thermoplastic polymer and producing process thereof |
| 12/14/2005 | CN1231492C Solution phase synthesis of oligonucleotides |
| 12/13/2005 | US6974869 Piperizinones as modulators of chemokine receptor activity |
| 12/13/2005 | CA2280151C Arylsulfonyl hydroxamic acid derivatives |
| 12/08/2005 | WO2005116027A2 Indazole and indolone derivatives and their use as pharmaceuticals |
| 12/08/2005 | WO2005115972A1 Therapeutic compounds |
| 12/08/2005 | US20050272931 Vanilloid receptor ligands and their use in treatments |
| 12/08/2005 | US20050272777 Vanilloid receptor ligands and their use in treatments |
| 12/08/2005 | US20050272638 Improved bioavailability; for oral and intracolonic administration |
| 12/08/2005 | DE102004024454A1 Neue Enantiomerenreine Betaagonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel New Enantiomerically pure beta agonists, to processes for their preparation and their use as medicaments |
| 12/08/2005 | CA2568050A1 Indazole and indolone derivatives and their use as pharmaceuticals |
| 12/08/2005 | CA2565066A1 Therapeutic compounds |
| 12/07/2005 | EP1602369A2 Bupropion Metabolites and Methods of their Synthesis and Use |
| 12/07/2005 | CN1705649A Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents |
| 12/06/2005 | US6972340 For therapy of diabetes, obesity, autoimmune disorders, acute and chronic inflammatory disorders, osteoporosis, cancer, malignant disorders |
| 12/06/2005 | CA2220389C Asymmetric synthesis of (-) 6-chloro-4-cyclopropyl-ethynyl-4-trifluoromethyl-1,4-dihydro-2h-3,1-benzoxazin-2-one |
| 12/01/2005 | WO2005113524A1 Fluorescent method and compounds to monitor protein-lipid binding |
| 12/01/2005 | US20050267163 Vanilloid receptor ligands and their use in treatments |
| 12/01/2005 | US20050267123 6-Membered heterocyclic compounds useful for selective inhibition of the coagulation cascade |